Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Forum
  • Discovery
  • About Us
    • Our Coverage
    • Team

ChemoMetec

330.60 DKK

+2.35 %

Less than 1K followers

CHEMM

NASDAQ Copenhagen

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Dividend
Investor consensus
Compare
+2.35 %
-17.27 %
-53.37 %
-51.91 %
-49.29 %
-30.84 %
-11.41 %
-50.06 %
+1,402.73 %

ChemoMetec specializes in the design, development, and production of patented instruments for cell counting and cell analysis. The company cooperates and statutes agreements with actors such as research institutes, universities, food companies, hospitals, and specialist clinics. Customers are found in a global market. The company was founded in 1997 and is headquartered in Alleröd, Denmark.

Read more
Market cap
5.75B DKK
Turnover
28.02M DKK
Revenue
495.57M
EBIT %
47.73 %
P/E
30.87
Dividend yield-%
2.12 %
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
10.9
2026

Annual report '26

8.10
2026

General meeting '26

All
Research
Press releases
ShowingAll content types
Regulatory press release3/27/2026, 9:06 AM

Notification of managers’ transactions

ChemoMetec
Regulatory press release3/27/2026, 9:06 AM

Indberetning af ledende medarbejderes transaktioner

ChemoMetec
Regulatory press release3/27/2026, 8:53 AM

Indberetning af ledende medarbejderes transaktioner

ChemoMetec

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release3/27/2026, 8:53 AM

Notification of managers’ transactions

ChemoMetec
Regulatory press release3/26/2026, 10:40 AM

Notification of managers’ transactions

ChemoMetec
Regulatory press release3/26/2026, 10:40 AM

Indberetning af ledende medarbejderes transaktioner

ChemoMetec
HCA Morgenbørs 26/03 - Røde futures fra morgenstunden
Video3/26/2026, 8:19 AM by
Michael Friis, Rasmus Køjborg

HCA Morgenbørs 26/03 - Røde futures fra morgenstunden

I dagens Morgenbørs ser vi ind i røde futures fra morgenstunden, Iran har ikke fundet afkørselsrampen. Herhjemme fokus på blandt andet Mærsk, Chemometec og Bioporto.

SP GroupGrønlandsbankenA.P. Møller - MærskChemoMetecØrstedVestas Wind SystemsBioPortoPandoraNovo Nordisk
HCA Morgenbørs 25/03 - Positive markeder og hele linjen
Video3/25/2026, 8:24 AM by
Rasmus Køjborg, Victor Skriver

HCA Morgenbørs 25/03 - Positive markeder og hele linjen

I dagens Morgenbørs ser vi med grønne futures-kurser ind i positive markeder over hele linjen. Herhjemme fokus på blandt andet Novonesis, SP Group, DFDS, Chemometec og B&O.

SP GroupDFDSTormHafniaBang & OlufsenD/S NordenFLSmidth & Co.NovonesisDanish Aerospace CompanyFirstFarmsChemoMetec
Regulatory press release3/24/2026, 3:08 PM

Justering af forventningerne til 2025/26

ChemoMetec
Regulatory press release3/24/2026, 3:08 PM

Adjustment of guidance for 2025/26

ChemoMetec
Regulatory press release3/2/2026, 9:50 AM

Notification of managers’ transactions

ChemoMetec
Regulatory press release3/2/2026, 9:50 AM

Indberetning af ledende medarbejderes transaktioner

ChemoMetec
Regulatory press release2/9/2026, 9:28 AM

Indberetning af ledende medarbejderes transaktioner

ChemoMetec
Regulatory press release2/9/2026, 9:28 AM

Notification of managers’ transactions

ChemoMetec
Regulatory press release2/4/2026, 5:16 PM

ChemoMetec enters Letter of Intent with Roche Diagnostics

ChemoMetec
Regulatory press release2/4/2026, 5:16 PM

ChemoMetec enters Letter of Intent with Roche Diagnostics

ChemoMetec
Regulatory press release2/4/2026, 5:09 PM

Interim report 2025/26 - Organic growth despite challenges in the North American market

ChemoMetec
Regulatory press release2/4/2026, 5:09 PM

1. halvår 2025/26 - Organisk vækst trods udfordringer på det nordamerikanske marked

ChemoMetec
HCA Morgenbørs 04/02 - Danske regnskaber i fokus
Video2/4/2026, 8:28 AM by
Victor Skriver, Rasmus Køjborg

HCA Morgenbørs 04/02 - Danske regnskaber i fokus

I dagens Morgenbørs ser vi ind i marginalt positive futures-markeder efter kursfaldene i går. Herhjemme i høj grad fokus på Novo Nordisk og andre større regnskabsaktuelle selskaber som DSV, Carlsberg, Lundbeck og NORDEN.

Novo NordiskDSVCarlsbergRingkjøbing LandbobankD/S NordenLundbeckAmbuChemoMetec
HCA Morgenbørs 23/01 - Udsigt til flad stemning i Europa med fokus på Novo Nordisk og Bavarian
Video1/23/2026, 8:17 AM by
Michael Friis, Rasmus Køjborg

HCA Morgenbørs 23/01 - Udsigt til flad stemning i Europa med fokus på Novo Nordisk og Bavarian

I dagens Morgenbørs ser vi ind i flade EU futures efter stor optur i går. Herhjemme fokus på Novo på receptal og Bavarian.

PandoraMT Højgaard HoldingNovo NordiskBavarian NordicA.P. Møller - MærskGN Store NordNordea BankFøroya BankiSkjern BankDanske Andelskassers BankAquaporinChemoMetecGomSpace GroupRovsingDanish Aerospace Company
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.